University of Michigan
University of Michigan Medical School
Ann Arbor, MI
Robert Silbergleit MD is a Professor of Emergency Medicine at University of Michigan. His research focuses on clinical trials of acute interventions for neurological emergencies including status epilepticus, cardiac arrest, stroke, and traumatic brain injury. He is a key investigator in the leadership of the NIH funded NETT and SIREN clinical trial networks. Dr. Silbergleit is dedicated to improving the structure, efficiency, and accountability of the clinical trial enterprise. He has been a co-investigator on a regulatory science grant from the NIH and FDA to investigate adaptive clinical trial methods in confirmatory phase trials, and is Principal Investigator on an NIH funded empirical ethics research project to study local context review by individual and centralized Institutional Review Boards. He has published and presented on issues relating to emergency research, consent, and exception from informed consent at meetings of PRM&R, and the Society for Clinical Trials.
Disclosure information not submitted.
Panel III: Exception from Informed Consent (EFIC) for Research at 25
Thursday, November 18, 2021
11:30 AM – 12:45 PM ET